Rare diseases
Investigational molecules
Locations
Back to Germany987 clinical trials in Heilbronn, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Tibulizumab to Treat Adults with Hidradenitis Suppurativa
GermanyStudy of zorevunersen to reduce seizures in patients with Dravet syndrome
GermanyStudy of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion
GermanyStudy of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness
GermanyStudy of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer
GermanyStudy of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease
GermanyStudy of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer
GermanyStudy of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)
GermanyStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)
GermanyStudy on the Effects and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy
GermanyStudy on the Safety and Immune Response of aQIVc HD Vaccine Compared to a Drug Combination for Adults 50 Years and Older at Risk of Flu Complications
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia, testing novel drug combinations to improve patient outcomes. Research includes evaluating treatments for both adult and pediatric patients with various forms of leukemia.
Studies aim to enhance survival rates and develop more effective treatment strategies for blood cancer patients.
Comprehensive studies addressing different types of breast cancer, particularly focusing on triple-negative breast cancer and HER2-positive disease. Research includes both early-stage and metastatic disease treatments.
Trials evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Research focusing on various digestive system cancers, including gastric cancer, colorectal cancer, and pancreatic cancer. Studies evaluate both early-stage and advanced disease treatments.
Investigations aim to improve surgical outcomes and treatment effectiveness for GI cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
